0000899243-20-002041.txt : 20200127 0000899243-20-002041.hdr.sgml : 20200127 20200127163127 ACCESSION NUMBER: 0000899243-20-002041 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200123 FILED AS OF DATE: 20200127 DATE AS OF CHANGE: 20200127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stuart Bryan CENTRAL INDEX KEY: 0001619846 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38978 FILM NUMBER: 20549951 MAIL ADDRESS: STREET 1: C/O CIVITAS THERAPEUTICS, INC. STREET 2: 190 EVERETT AVENUE CITY: CHELSEA STATE: MA ZIP: 02150 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc. CENTRAL INDEX KEY: 0001680581 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474839948 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-651-8851 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-23 0 0001680581 Fulcrum Therapeutics, Inc. FULC 0001619846 Stuart Bryan C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Operating Officer Stock Option (right to buy) 16.87 2020-01-23 4 A 0 105000 0.00 A 2030-01-22 Common Stock 105000 105000 D This option was granted on January 23, 2020 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2020, subject to continued service. /s/ Peter Thomson, as attorney-in-fact for Bryan Stuart 2020-01-27